Literature DB >> 7540399

Lymphocytotropic strains of HIV type 1 when complexed with enhancing antibodies can infect macrophages via Fc gamma RIII, independently of CD4.

H Trischmann1, D Davis, P J Lachmann.   

Abstract

Antipeptide sera raised against the gp120/gp41 sequences of human immunodeficiency virus type 1 (HIV-1) were used to determine their capacity to enhance infection. Antisera to the five variable regions (V1 to V5) of gp120 and conserved parts of gp120 and gp41 facilitated infection of primary human macrophages with the homologous virus HIV-1 SF2mc. In contrast, heterologous virus infection with HTLV-IIIB was mediated only by antisera to the conserved regions, predominantly C4 and C5. Heterologous virus infection occurred more rapidly and was consistent between different cell donors. The neutralizing monoclonal antibody (MAb) SC258 (murine IgG2a) but not MAb 684-238 (mIgG1) against conformational epitopes of the V2 region also induced antibody-dependent infection enhancement (ADE). Therefore, preincubation with certain antibodies can cause altered tropism of the lymphocytotropic viruses mentioned above. Viral infection was completely abolished by preincubation with the F(ab)2 fragment of MAb 3G8 against the Fc gamma receptor III (CD16). A MAb (7.3F11) against the gp120-binding site of CD4 had no effect on viral infectivity. Possible mechanisms and their implications for disease progression are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540399     DOI: 10.1089/aid.1995.11.343

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

Review 1.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.

Authors:  Ramu A Subbramanian; Jingwu Xu; Emil Toma; Richard Morisset; Eric A Cohen; José Menezes; Ali Ahmad
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages.

Authors:  Annie David; Asier Sáez-Cirión; Pierre Versmisse; Odile Malbec; Bruno Iannascoli; Florence Herschke; Marianne Lucas; Françoise Barré-Sinoussi; Jean-François Mouscadet; Marc Daëron; Gianfranco Pancino
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

4.  Human retinal microglia express candidate receptors for HIV-1 infection.

Authors:  V T Pham; L Wen; P McCluskey; M C Madigan; P L Penfold
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection.

Authors:  B A Lidbury; S Mahalingam
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 6.  Applications of flow cytometry to clinical microbiology.

Authors:  A Alvarez-Barrientos; J Arroyo; R Cantón; C Nombela; M Sánchez-Pérez
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.

Authors:  Lautaro G Perez; Matthew R Costa; Christopher A Todd; Barton F Haynes; David C Montefiori
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

8.  Antibody-dependent enhancement of hepatitis C virus infection.

Authors:  Keith Meyer; Malika Ait-Goughoulte; Zhen-Yong Keck; Steven Foung; Ranjit Ray
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  Danielle Perez-Bercoff; Annie David; Hugues Sudry; Françoise Barré-Sinoussi; Gianfranco Pancino
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies.

Authors:  Vincent Holl; Maryse Peressin; Christiane Moog
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.